Streptomyces spectabilis

Streptomyces spectabilis is a bacterium species from the genus of Streptomyces.^[1][3][4] Streptomyces spectabilis produces hangtaimycin, gentamicin, kanamycin, neomycin B, sisomycin, tobramycin, paromomycin, spectinabilin, aminocyclitol, actinospectacin, prodigiosine and the streptovaricin complex.^{[4][5][6][7][8][9][10]}

Further reading

• Kim, Kyoung-Rok; Kim, Tae-Jong; Suh, Joo-Won (29 July 2008). "The Gene Cluster for Spectinomycin Biosynthesis and the Aminoglycoside-Resistance Function of spcM in Streptomyces spectabilis". Current Microbiology. 57 (4): 371–374. doi:10.1007/s00284-008-9204-y. 
• Isaka, M.; Jaturapat, A.; Kramyu, J.; Tanticharoen, M.; Thebtaranonth, Y. (1 April 2002). "Potent In Vitro Antimalarial Activity of Metacycloprodigiosin Isolated from Streptomycesspectabilis BCC 4785". Antimicrobial Agents and Chemotherapy. 46 (4): 1112–1113. doi:10.1128/AAC.46.4.1112-1113.2002. 
• HOEKSEMA, HERMAN; KNIGHT, JOHN C. (1975). "The production of dihydrospectinomycin by Syreptomyces spect abilis.". The Journal of Antibiotics. 28 (3): 240–241. doi:10.7164/antibiotics.28.240. 
• Selvakumar, JN; Chandrasekaran, SD; Vaithilingam, M (October 2015). "Bio Prospecting of Marine-derived Streptomyces spectabilis VITJS10 and Exploring its Cytotoxicity Against Human Liver Cancer Cell Lines.". Pharmacognosy magazine. 11 (Suppl 3): S469–73. doi:10.4103/0973-1296.168974. PMC 4745219. PMID 26929583. 
• Staley, AL; Rinehart, KL (December 1994). "Spectomycins, new antibacterial compounds produced by Streptomyces spectabilis: isolation, structures, and biosynthesis.". The Journal of antibiotics. 47 (12): 1425–33. doi:10.7164/antibiotics.47.1425. PMID 7844036. 
• Atta-ur-Rahman, edited by (2000). Bioactive natural products. Amsterdam: Elsevier. ISBN 0-08-054202-6. 
• ed.-in-chief, George M. Garrity (2012). Bergey's manual of systematic bacteriology. (2nd ed.). New York: Springer Science + Business Media. ISBN 0-387-68233-3. 
• Arya, Dev P. (2007). Aminoglycoside antibiotics from chemical biology to drug discovery. Hoboken, N.J.: Wiley-Interscience. ISBN 0-470-14966-3. 
• Brossi, edited by Arnold (1985). The alkaloids chemistry and pharmacology. Orlando: Academic Press. ISBN 0-08-086549-6. 
• Corcoran, edited by John W. (1981). Biosynthesis. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-67724-X. 
• Stephen W., Queener (1986). Antibiotic- Producing Stetomyces. Oxford: Elsevier Science. ISBN 0-323-16293-2. 

See also

• List of Streptomyces species

References

1. 1 2 LPSN bacterio.net
2. ↑ Straininfo of Streptomyces spectabilis
3. ↑ UniProt
4. 1 2 Deutsche Sammlung von Mikroorganismen und Zellkulturen
5. ↑ Kakinuma, K.; Hanson, C.A.; Rinehart, K.L. (January 1976). "Spectinabilin, a new nitro-containing metabolite isolated from streptomyces spectabilis". Tetrahedron. 32 (2): 217–222. doi:10.1016/0040-4020(76)87004-4. 
6. ↑ editors, Satinder Kaur Brar, Gurpreet Singh Dhillon, Carlos Ricardo Soccol, (2014). Biotransformation of Waste Biomass into High Value Biochemicals. New York, NY: Springer New York. ISBN 1-4614-8005-1. 
7. ↑ editors, Thomas J. Dougherty, Michael J. Pucci, (2012). Antibiotic discovery and development (2012. ed.). New York: Springer. ISBN 1-4614-1400-8. 
8. ↑ Mordarski, edited by M. Goodfellow, S.T. Williams, M. (1988). Actinomycetes in Biotechnology. Oxford: Elsevier Science. ISBN 0-08-098433-9. 
9. ↑ J., Elks (1990). Dictionary of Drugs Chemical Data, Structures and Bibliographies. Boston, MA: Springer US. ISBN 1-4757-2085-8. 
10. ↑ Zuo, Lijie; Jiang, Bingya; Jiang, Zhibo; Zhao, Wei; Li, Shufen; Liu, Hongyu; Hong, Bin; Yu, Liyan; Zuo, Limin; Wu, Linzhuan (9 March 2016). "Hangtaimycin, a peptide secondary metabolite discovered from Streptomyces spectabilis CPCC 200148 by chemical screening". The Journal of Antibiotics. doi:10.1038/ja.2016.29.